It sure seems to be.
Look at how many potential candidates were out there and the new types of technologies. I understand that the contracts we signed are with the seven that showed the greatest promise, not the least of which are the Pfizer and Moderna vaccines. Coming shortly thereafter is going to be the AstraZeneca vaccine and Novavax. Those were all identified by the group. I think figuring that part out was absolutely critical.